|
|
|
|
LEADER |
01000cam a2200265 4500 |
001 |
689201362 |
003 |
DE-627 |
005 |
20230905072154.0 |
007 |
cr uuu---uuuuu |
008 |
120321s2012 gw |||||om 00| ||ger c |
015 |
|
|
|a 18,O07
|2 dnb
|
016 |
7 |
|
|a 1160517851
|2 DE-101
|
024 |
7 |
|
|a urn:nbn:de:bsz:21-opus-61025
|2 urn
|
035 |
|
|
|a (DE-627)689201362
|
035 |
|
|
|a (DE-576)362232016
|
035 |
|
|
|a (DE-599)BSZ362232016
|
035 |
|
|
|a (OCoLC)984840729
|
035 |
|
|
|a (OCoLC)984840729
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a ger
|
044 |
|
|
|c XA-DE-BW
|
082 |
0 |
4 |
|a 610
|
100 |
1 |
|
|a Müller-Ide, Hendrik
|e verfasserin
|0 (DE-627)1432231871
|0 (DE-576)362231877
|4 aut
|
245 |
1 |
0 |
|a Identifikation des HIV-Proteaseinhibitors Ritonavir als Medikament mit potentieller Wirksamkeit in der Therapie der Akuten Myeloischen Leukämie in Kombination mit Proteasominhibitoren
|c vorgelegt von Hendrik Müller-Ide
|
264 |
|
1 |
|c 2012
|
300 |
|
|
|a Online-Ressource
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
502 |
|
|
|a Tübingen, Univ., Diss., 2012
|
583 |
1 |
|
|a Archivierung/Langzeitarchivierung gewährleistet
|2 pdager
|5 DE-101
|
650 |
0 |
7 |
|0 (DE-588)4245523-6
|0 (DE-627)104229934
|0 (DE-576)210472073
|a Akute myeloische Leukämie
|2 gnd
|
650 |
0 |
7 |
|0 (DE-588)4315827-4
|0 (DE-627)126601801
|0 (DE-576)21117730X
|a Proteasom
|2 gnd
|
650 |
0 |
7 |
|0 (DE-588)4022796-0
|0 (DE-627)106306960
|0 (DE-576)208945857
|a Hämatologie
|2 gnd
|
650 |
0 |
7 |
|0 (DE-588)4194534-7
|0 (DE-627)105218766
|0 (DE-576)210094818
|a Kombinationstherapie
|2 gnd
|
650 |
0 |
7 |
|0 (DE-588)4687890-7
|0 (DE-627)349394067
|0 (DE-576)215046412
|a HIV-Proteaseinhibitor
|2 gnd
|
655 |
|
7 |
|a Hochschulschrift
|0 (DE-588)4113937-9
|0 (DE-627)105825778
|0 (DE-576)209480580
|2 gnd-content
|
751 |
|
|
|a Tübingen
|0 (DE-588)4061147-4
|0 (DE-627)106136933
|0 (DE-576)209138351
|4 uvp
|
776 |
0 |
8 |
|i Druckausg. u.d.T.
|a Müller-Ide, Hendrik
|t Identifikation des HIV-Proteaseinhibitors Ritonavir als Medikament mit potentieller Wirksamkeit in der Therapie der Akuten Myeloischen Leukämie in Kombination mit Proteasominhibitoren
|d 2012
|h 112 S.
|w (DE-627)1432232169
|w (DE-576)362232164
|
856 |
4 |
0 |
|u http://nbn-resolving.de/urn:nbn:de:bsz:21-opus-61025
|q application/pdf
|x Resolving-System
|z kostenfrei
|3 Volltext
|
856 |
4 |
0 |
|u http://d-nb.info/1160517851/34
|v 2018-07-05
|x Langzeitarchivierung Nationalbibliothek
|3 Volltext
|
856 |
4 |
0 |
|u https://publikationen.uni-tuebingen.de/xmlui/handle/10900/45960/
|v 2018-07-05
|x Verlag
|z kostenfrei
|3 Volltext
|
912 |
|
|
|a GBV-ODiss
|
912 |
|
|
|a GBV_ILN_20
|
912 |
|
|
|a ISIL_DE-84
|
912 |
|
|
|a SYSFLAG_1
|
912 |
|
|
|a GBV_KXP
|
912 |
|
|
|a SSG-OLC-PHA
|
912 |
|
|
|a SSG-OPC-PHA
|
912 |
|
|
|a SSG-OPC-DE-84
|
912 |
|
|
|a GBV_ILN_21
|
912 |
|
|
|a ISIL_DE-46
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a ISIL_DE-18
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a ISIL_DE-7
|
912 |
|
|
|a GBV_ILN_60
|
912 |
|
|
|a ISIL_DE-705
|
912 |
|
|
|a GBV_ILN_65
|
912 |
|
|
|a ISIL_DE-3
|
912 |
|
|
|a GBV_ILN_105
|
912 |
|
|
|a ISIL_DE-841
|
912 |
|
|
|a GBV_ILN_132
|
912 |
|
|
|a ISIL_DE-959
|
912 |
|
|
|a GBV_ILN_161
|
912 |
|
|
|a ISIL_DE-960
|
912 |
|
|
|a GBV_ILN_213
|
912 |
|
|
|a ISIL_DE-551
|
912 |
|
|
|a GBV_ILN_230
|
912 |
|
|
|a ISIL_DE-552
|
912 |
|
|
|a GBV_ILN_293
|
912 |
|
|
|a ISIL_DE-960-3
|
912 |
|
|
|a GBV_ILN_2001
|
912 |
|
|
|a ISIL_DE-21
|
912 |
|
|
|a GBV_ILN_2403
|
912 |
|
|
|a ISIL_DE-LFER
|
935 |
|
|
|i Blocktest
|
951 |
|
|
|a BO
|
980 |
|
|
|2 20
|1 01
|x 0084
|b 1782695915
|y x
|z 09-07-18
|
980 |
|
|
|2 21
|1 01
|x 0046
|b 1782726950
|y z
|z 09-07-18
|
980 |
|
|
|2 22
|1 01
|x 0018
|b 1782755942
|h SUBolrd
|y xu
|z 09-07-18
|
980 |
|
|
|2 40
|1 01
|x 0007
|b 1782797769
|y xsn
|z 09-07-18
|
980 |
|
|
|2 60
|1 01
|x 0705
|b 1782826831
|h OLRD
|y z
|z 09-07-18
|
980 |
|
|
|2 65
|1 01
|x 0003
|b 4166245082
|h GBV-ODiss
|k Open Access
|y z
|z 14-07-22
|
980 |
|
|
|2 105
|1 01
|x 0841
|b 1782986006
|y z
|z 09-07-18
|
980 |
|
|
|2 132
|1 01
|x 0959
|b 1782890823
|h OLR-DISS
|y x
|z 09-07-18
|
980 |
|
|
|2 161
|1 01
|x 0960
|b 1782921222
|h ORD
|y z
|z 09-07-18
|
980 |
|
|
|2 213
|1 01
|x 0551
|b 1788038703
|h ORD
|y x
|z 26-07-18
|
980 |
|
|
|2 230
|1 01
|x 0552
|b 1788077105
|h ORD
|y x
|z 26-07-18
|
980 |
|
|
|2 293
|1 01
|x 3293
|b 1782955038
|h ORD
|y z
|z 09-07-18
|
980 |
|
|
|2 2001
|1 01
|x DE-21
|b 3346437043
|c 00
|f --%%--
|d --%%--
|e --%%--
|j --%%--
|y l01
|z 21-03-12
|
980 |
|
|
|2 2403
|1 01
|x DE-LFER
|b 334643706X
|c 00
|f --%%--
|d --%%--
|e n
|j --%%--
|y l01
|z 17-04-12
|
981 |
|
|
|2 20
|1 01
|x 0084
|r http://nbn-resolving.de/urn:nbn:de:bsz:21-opus-61025
|
981 |
|
|
|2 21
|1 01
|x 0046
|r http://nbn-resolving.de/urn:nbn:de:bsz:21-opus-61025
|
981 |
|
|
|2 22
|1 01
|x 0018
|r http://nbn-resolving.de/urn:nbn:de:bsz:21-opus-61025
|
981 |
|
|
|2 40
|1 01
|x 0007
|r http://nbn-resolving.de/urn:nbn:de:bsz:21-opus-61025
|
981 |
|
|
|2 60
|1 01
|x 0705
|r http://nbn-resolving.de/urn:nbn:de:bsz:21-opus-61025
|
981 |
|
|
|2 65
|1 01
|x 0003
|r http://nbn-resolving.de/urn:nbn:de:bsz:21-opus-61025
|
981 |
|
|
|2 105
|1 01
|x 0841
|r http://nbn-resolving.de/urn:nbn:de:bsz:21-opus-61025
|
981 |
|
|
|2 132
|1 01
|x 0959
|r http://nbn-resolving.de/urn:nbn:de:bsz:21-opus-61025
|
981 |
|
|
|2 161
|1 01
|x 0960
|r http://nbn-resolving.de/urn:nbn:de:bsz:21-opus-61025
|
981 |
|
|
|2 213
|1 01
|x 0551
|r http://nbn-resolving.de/urn:nbn:de:bsz:21-opus-61025
|
981 |
|
|
|2 230
|1 01
|x 0552
|r http://nbn-resolving.de/urn:nbn:de:bsz:21-opus-61025
|
981 |
|
|
|2 293
|1 01
|x 3293
|r http://nbn-resolving.de/urn:nbn:de:bsz:21-opus-61025
|
981 |
|
|
|2 2403
|1 01
|x DE-LFER
|r http://nbn-resolving.de/urn:nbn:de:bsz:21-opus-61025
|
982 |
|
|
|2 2001
|1 01
|x DE-21
|8 00
|s s
|a Ritonavir
|
982 |
|
|
|2 2001
|1 01
|x DE-21
|8 01
|s s
|a Bortezomib
|
982 |
|
|
|2 2001
|1 01
|x DE-21
|8 02
|s s
|a Daunorubicin
|
982 |
|
|
|2 2001
|1 01
|x DE-21
|8 03
|s s
|a ER-Stress
|
982 |
|
|
|2 2001
|1 01
|x DE-21
|8 04
|s s
|a Apoptose
|
982 |
|
|
|2 2001
|1 01
|x DE-21
|8 05
|s s
|a Proteasome
|
982 |
|
|
|2 2001
|1 01
|x DE-21
|8 06
|s s
|a Combination
|
982 |
|
|
|2 2001
|1 01
|x DE-21
|8 07
|s s
|a ER stress
|
983 |
|
|
|2 60
|1 01
|x 0705
|8 10
|a ho
|
985 |
|
|
|2 20
|1 01
|x 0084
|a OLRD
|
995 |
|
|
|2 22
|1 01
|x 0018
|a SUBolrd
|
995 |
|
|
|2 60
|1 01
|x 0705
|a OLRD
|
995 |
|
|
|2 65
|1 01
|x 0003
|a GBV-ODiss
|
995 |
|
|
|2 132
|1 01
|x 0959
|a OLR-DISS
|
995 |
|
|
|2 161
|1 01
|x 0960
|a ORD
|
995 |
|
|
|2 213
|1 01
|x 0551
|a ORD
|
995 |
|
|
|2 230
|1 01
|x 0552
|a ORD
|
995 |
|
|
|2 293
|1 01
|x 3293
|a ORD
|